ScholarIQanswers from OpenAlex
Institut de Cancérologie Strasbourg
InstitutionResearch output, impact & collaborations
Institut de Cancérologie Strasbourg is a institution indexed in ScholarIQ from OpenAlex.
What is known about Institut de Cancérologie Strasbourg?
ScholarIQrecord summary
Institut de Cancérologie Strasbourg is a research organisation in Strasbourg, FR. OpenAlex records 1,846 works and 39,636 citations for it. 423 researchers list it as their most recent affiliation.
How many works does Institut de Cancérologie Strasbourg have?
ScholarIQindexed works
Institut de Cancérologie Strasbourg has 1,846 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Institut de Cancérologie Strasbourg have?
ScholarIQcitation count
Institut de Cancérologie Strasbourg has 39,636 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Institut de Cancérologie Strasbourg?
ScholarIQresearcher count
Institut de Cancérologie Strasbourg has 423 researchers in the ScholarIQ index.
What is the average h-index at Institut de Cancérologie Strasbourg?
ScholarIQavg h-index
Institut de Cancérologie Strasbourg has an average h-index of 88 in OpenAlex.
What is the ROR of Institut de Cancérologie Strasbourg?
ScholarIQror
The ROR for Institut de Cancérologie Strasbourg is on the source record.
What is the OpenAlex record for Institut de Cancérologie Strasbourg?
ScholarIQopenalex
The OpenAlex for Institut de Cancérologie Strasbourg is on the source record.
Who are the most-cited researchers behind Institut de Cancérologie Strasbourg?
ScholarIQtop researchers by citations
What are the most-cited papers on Institut de Cancérologie Strasbourg?
ScholarIQmost cited works
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Georg Heß, Raoul Herbrecht, Jorge Romaguera, Gregor Verhoef, Michael Crump, Christian Gisselbrecht, Anna Laurell, Fritz Offner, Andrew Strahs, Anna Berkenblit, Orysia Hanushevsky, Jill S. Clancy, Becker Hewes, Laurence Moore, Bertrand Coiffier
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
Livio Pagano, Jon Salmanton‐García, Francesco Marchesi, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Н Н Климко, Philipp Koehler, Antonio Pagliuca, Francesco Passamonti, Luisa Verga, Benjamín Víšek, Osman İlhan, Gianpaolo Nadali, Barbora Weinbergerová, Raúl Córdoba, Monia Marchetti, Graham P. Collins, Francesca Farina, Chiara Cattaneo, Alba Cabirta, María Gomes da Silva, Federico Itri, Jaap A. van Doesum, Marie‐Pierre Ledoux, Martin Čerňan, Ozren Jakšić, Rafael F. Duarte, Gabriele Magliano, Ali S. Omrani, Nicola Fracchiolla, Austin Kulasekararaj, Toni Valković, Christian Bjørn Poulsen, Marina Machado, Andreas Glenthøj, И. О. Стома, Zdeněk Ráčil, Klára Piukovics, Milan Navrátil, Ziad Emarah, Uluhan Sili, Johan Maertens, Ola Blennow, Rui Bergantim, Carolina García‐Vidal, Lucia Prezioso, Anna Guidetti, Maria Ilaria Del Principe, Marina Popova, Nick de Jonge, Irati Ormazabal‐Vélez, Noemí Fernández, Iker Falces‐Romero, Annarosa Cuccaro, Stef Meers, Caterina Buquicchio, Darko Antić, Murtadha Al‐Khabori, Ramón García‐Sánz, Monika Biernat, Maria Chiara Tisi, Ertan Sal, Laman Rahimli, Nataša Čolović, Martin Schönlein, María Calbacho, Carlo Tascini, Carolina Miranda, Nina Khanna, Gustavo‐Adolfo Méndez, Verena Petzer, Jan Novák, Caroline Besson, Rémy Duléry, Sylvain Lamure, Márcio Nucci, Giovanni Paolo Maria Zambrotta, Павел Зак, Güldane Cengiz Seval, Valentina Bonuomo, Jiřı́ Mayer, Alberto López‐García, Maria Vittoria Sacchi, Stephen Booth, Fabio Ciceri, Margherita Oberti, Marco Salvini, Macarena Izuzquiza, Raquel Nunes Rodrigues, Emanuele Ammatuna, Aleš Obr, Raoul Herbrecht, Lucía Núñez-Martín-Buitrago, Valentina Mancini, Hawraa Shwaylia, Mariarita Sciumé, Jenna Essame, Marietta Nygaard, Josip Batinić
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies
Denis Caillot, Anne Thiébaut, Raoul Herbrecht, Stéphane de Botton, Arnaud Pigneux, Frédéric Bernard, Jérôme Larché, Françoise Monchecourt, S. Alfandari, L. Mahi
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis
Fanny Lanternier, S. Poirée, C. Elie, Dea Garcia‐Hermoso, Prissile Bakouboula, Karine Sitbon, Raoul Herbrecht, Michel Wolff, Patricia Ribaud, O. Lortholary
How much of the research on Institut de Cancérologie Strasbourg is open access?
ScholarIQopen access share
75%OPEN ACCESS